|
Market Cap (2-Jul) $57,232,348 (840th) |
Close (30-Jun) $0.86 |
Volume (30-Jun) 64,140 |
Shortsold (19-Jun) 737,517 (0.45%) (320th) |
|
52w High $1.12 |
52w Low $0.285 |
P/E - |
EPS -0.06 |
PIQ released this announcement to the ASX on 19 October 2022, 12:45. The announcement is not marked as price sensitive, and is 30 page(s) in length and 2.09MB in size.
You can view all announcements from PIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, PIQ was 0.000% short sold according to ASIC data. It was ranked the 654th most shorted stock on the ASX. It is now ranked as the 320th most shorted stock on the ASX with 0.451% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PIQ | |
|---|---|
| Sonic Healthcare USA signs licence for PromarkerD in the US | 10 May 2023, 11:41 |
| Trading Halt | 8 May 2023, 9:15 |
| World Endometriosis Congress - New diagnostic test showcased | 5 May 2023, 8:15 |
| Notice of Annual General Meeting/Proxy Form | 19 October 2022, 12:45 |
| Proteomics receives $1.7 million in R&D tax incentive | 17 October 2022, 8:11 |
| Notification of cessation of securities - PIQ | 14 October 2022, 12:40 |
| New Oesophageal Cancer Diagnostic shows strong performance | 27 September 2022, 8:19 |
You must be logged in to post a reply.
Proteomics International Laboratories 